COVID-19 Vaccines

More than 70% of Philadelphians are vaccinated, and the health department aims to reach the remaining third.

Federal health officials say millions more Americans can get a COVID-19 booster and choose a different vaccine for that next shot.

The Food and Drug Administration authorized booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson following unanimous votes by a committee.

All future contractors for the state of New Jersey must prove that they or their employees are vaccinated or be subjected to weekly testing for COVID-19.

Plus, less than a quarter of all firefighters submitted proof of vaccination. Officials again declined to impose a tougher mandate on municipal workers.

Within hours of formal approval, expected after the CDC advisory meeting scheduled for Nov. 2-3, COVID vaccine doses will begin shipping to providers across the country,

Penn Med researchers found that memory T and B cells play a significant role in fighting COVID-19 even 6 months after vaccination.

The upcoming FDA announcement is likely to come along with authorization for boosters of the Moderna and J&J shots and follows the authorization of a third dose for Pfizer.

Those who qualify for vaccine booster shots can now book appointments through the state’s scheduling system.

Much of the world is open to Americans, particularly vaccinated travelers, but the rules vary. Here’s what you need to know before you go.

Citing an issue with the vendor, N.J. officials have granted "limited and targeted flexibility" for COVID testing requirements for school district employees.

In a 19-0 vote, the panel recommended that the booster dose come at least two months after initial immunization with one shot of the J&J vaccine.

The advisers to the Food and Drug Administration voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups.

Philadelphia’s health commissioner said the city risks another epidemic of preventable deaths if health care workers don’t get inoculated against the coronavirus.

After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters.